NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the “Company”), and a clinical stage, leading global ...

NanoViricides, Inc. (NYSE American: NNVC) , a clinical-stage pioneer in host-mimetic nanomedicine, affirmed its preparedness to address the continued ...

While WHO member states have agreed to adopt this agreement, there are still questions on implementation and accountability.

The Director-General of the World Health Organization (WHO) is hereby transmitting the report of the fourth meeting of the International Health Regulations (2005) (IHR) Emergency Committee (Committee) ...

The Director-General of the World Health Organization (WHO) is hereby transmitting the report of the fourth meeting of the ...

The World Health Organization (WHO) has renewed its declaration that Mpox (formerly monkeypox) remains a Public Health Emergency of International Concern (PHEIC). WHO Director-General Dr. Tedros ...

World Health Organization (WHO) Director-General Dr Tedros Adhanom Ghebreyesus has determined that the upsurge of mpox in the Democratic Republic of the Congo (DRC) and a growing number of countries ...